Brief: Camurus Announces Expansion Of Lilly Collaboration

Eli Lilly and Co

01/06/2026 16:04

June 1 (Reuters) - Camurus AB CAMX.ST:
CAMURUS ANNOUNCES EXPANSION OF LILLY COLLABORATION
ELI LILLY EXERCISES OPTION TO INCLUDE AMYLIN RECEPTOR AGONISTS IN CAMURUS COLLABORATION
AGREEMENT COVERS UP TO FOUR LILLY DRUG COMPOUNDS ACROSS THREE CLASSES
LILLY'S EXCLUSIVE GLOBAL RIGHTS TO FLUIDCRYSTAL TECHNOLOGY EXTENDED TO ADDITIONAL COMPOUND CLASS
ELIGIBLE FOR UP TO $290 MILLION UPFRONT, $580 MILLION SALES MILESTONES, PLUS ROYALTIES
OPTION EXERCISE TRIGGERS $5 MILLION INITIAL PAYMENT TO CAMURUS
Source text: ID:nWkr6FZcvJ
Further company coverage: CAMX.ST

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))